SCHEMBL5227738

SCHEMBL5227738

COc1[c]c2ccccc2cc1.COc1[c]c2ccccc2cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
MAPT P10636 1/20 0.36
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPK1 P28482 1/20 0.36
NQO1 P15559 1/20 0.34
CA4 P22748 2/20 0.33
POLB P06746 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
NQO2 P16083 3/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
NPC1 O15118 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64917 1.00 CYP1A2 (0.40) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2
SCHEMBL7648281 0.86 PDE4B (0.32) CYP1A2CYP2A6MAPTPOLB
SCHEMBL4744273 0.82 CYP3A4 (0.31)
SCHEMBL20524986 0.82 CYP2A6 (0.32) CYP2A6ALDH1A1
SCHEMBL357540 0.82 CYP2A6 (0.45) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2
SCHEMBL9558600 0.80 KMT2A (0.32) MAPTNPC1RAB9A
SCHEMBL2214680 0.79 CYP1A2 (0.31) CYP1A2CYP2A6
SCHEMBL6945091 0.79 PTPN1 (0.33) CYP1A2CYP2A6
SCHEMBL2502936 0.79 PTPN1 (0.33) CYP1A2CYP2A6
SCHEMBL8691514 0.79 HPRT1 (0.45) CYP1A2CYP2A6MAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11186660-B2 Internal electron donor compound for preparing α-olefin polymerization catalyst component YINGKOU XIANGYANG CATALYST CO., LTD. 2021-11-30 US disclosed
US-20190218317-A1 INTERNAL ELECTRON DONOR COMPOUND FOR PREPARING ALPHA-OLEFIN POLYMERIZATION CATALYST COMPONENT YINGKOU XIANGYANG CATALYST CO LTD (CN) 2019-07-18 US disclosed
EP-1412336-A4 PEPTOID COMPOUNDS UNIV WOLLONGONG (AU) 2007-08-29 EP disclosed
US-6855657-B2 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions THE PENN STATE RESEARCH FOUNDATION (US) 2005-02-15 US disclosed
EP-1412336-A1 PEPTOID COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2004-04-28 EP disclosed
US-20040068126-A1 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions THE PENN STATE RESEARCH FOUNDATION 2004-04-08 US disclosed
WO-2003002545-A1 PEPTOID COMPOUNDS UNIVERSITY OF WOLLONGONG (AU) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068126-A1 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions BCKDK, PDK3, HCK CYP1A2 1070/4885CYP2A6 1744/4885MAPT 3573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.